Intelligent Systems Announces Third Quarter and

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Intelligent Systems Announces Third Quarter and Year-To-Date 2016 Results

NORCROSS, Ga., Nov. 14, 2016 (GLOBE NEWSWIRE) -- Intelligent Systems Corporation (NYSE MKT:INS) announced today its financial results for the three and nine month periods ended September 30, 2016. 

Revenue was $2,649,000 and $5,844,000 in the three and nine month periods ended September 30, 2016, respectively, representing growth of 115 percent and 67 percent, respectively, as compared to the same periods in 2015.  The growth in both product and services revenue is attributable to the initial implementation of a global license customer in the third quarter of 2016 as well as expansion of our processing services customer base and an upswing in our professional services to support both new and existing customers.  

For the three month period ended September 30, 2016, the company recorded net income attributable to Intelligent Systems of $123,000 ($0.01 per basic and diluted share) compared to a net loss attributable to Intelligent Systems of $424,000 ($0.05 per basic and diluted share) in the third quarter of 2015. The strong revenue growth for the quarter while maintaining operating expenses below the comparable period in the prior year resulted in a $547,000 positive swing in profits for the third quarter of 2016 as compared to the same period in 2015.

For the year-to-date period ended September 30, 2016, the company recorded net loss attributable to Intelligent Systems Corporation of $1,032,000 ($0.12 per basic and diluted share). Included in the year-to-date loss is a previously reported $750,000 impairment charge reducing the carrying value of our minority equity ownership in an early stage sensor technology company. In the comparable nine month period in 2015, the company recorded net income attributable to Intelligent Systems of $17,080,000 ($1.93 per basic share and $1.91 per diluted share). The dramatic change between periods reflects the gain of $18,726,000 on the sale of the company’s former ChemFree subsidiary in the year-to-date period in 2015.  As previously reported, the company sold its ChemFree subsidiary on March 31, 2015 and consequently has classified the ChemFree business as discontinued operations for all periods presented.

“Being up year-over-year for the third quarter in revenue and earnings from on-going CoreCard operations translated into the same results for Intelligent Systems and is welcome from both a management and shareholder perspective,” said Leland Strange, CEO of Intelligent Systems. “I can imagine some shareholders feel like I do – ‘it’s about time’!  We feel good about the rest of the year while cautioning that we will continue to add resources and infrastructure to take advantage of the unique combination of technology, people and capabilities that CoreCard offers in the FinTech arena. We will still see some variations on a quarter-to-quarter basis as revenue recognition is somewhat dependent on when some of our larger customers determine to ‘pull the trigger’ and go live.”

The company will file its Form 10-Q for the period ended September 30, 2016 with the Securities and Exchange Commission today, November 14, 2016. For additional information about reported results, investors will be able to access the Form 10-Q on the company’s website at www.intelsys.com or on the SEC site, www.sec.gov . 

About Intelligent Systems Corporation

For over thirty-five years, Intelligent Systems Corporation (NYSE MKT:INS) has identified, created, operated and grown technology companies. The company’s principal continuing operations include CoreCard Software, Inc. ( www.corecard.com ) and its affiliate companies. CoreCard designs, develops, and markets a comprehensive suite of software solutions to corporations, financial institutions, retailers and processors to manage their credit and debit cards, prepaid cards, private label cards, fleet cards, loyalty programs, and accounts receivable and small loan transactions. CoreCard is a unique partner for FinTech innovators by providing them a comprehensive platform for their payment and processing solutions. CoreCard also offers prepaid and credit card processing services using its proprietary software solutions.   Further information is available on the company’s website at www.intelsys.com or by calling the company at 770/381-2900.

In addition to historical information, this news release may contain forward-looking statements relating to Intelligent Systems Corporation and its subsidiary and affiliated companies. These statements include all statements that are not statements of historical fact regarding the intent, belief or expectations of Intelligent Systems Corporation and its management with respect to, among other things, results of operations, product plans, and financial condition. The words "may," "will," "anticipate," "believe," "intend," "expect," "estimate," "plan," "strategy" and similar expressions are intended to identify forward-looking statements.  Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties and that actual results may differ materially from those contemplated by such forward-looking statements. The company does not undertake to update or revise any forward-looking statements whether as a result of new developments or otherwise, except as required by law. Among the factors that could cause actual results to differ materially from those indicated by such forward-looking statements are instability in the financial markets, delays in product development, undetected software errors, competitive pressures, changes in customers’ requirements or financial condition, market acceptance of products and services, and declines in general economic and financial market conditions, particularly those that cause businesses to delay or cancel purchase decisions.

     
  CONSOLIDATED STATEMENTS OF OPERATIONS  
  (unaudited, in thousands, except share and per share amounts)  
     
        Three Months Ended Sept. 30,    Nine Months Ended Sept. 30,  
          2016     2015     2016     2015  
  Revenue                            
  Products     $ 518   $ 139   $ 896   $ 413  
  Services       2,131     1,093     4,948     3,096  
  Total net revenue       2,649     1,232     5,844     3,509  
  Cost of revenue                            
  Products       449     55     571     166  
  Services       976     603     2,342     1,774  
  Total cost of revenue       1,425     658     2,913     1,940  
  Expenses                            
  Marketing       80     58     274     180  
  General and administrative       376     433     1,315     1,527  
  Research and development       637     703     1,893     2,114  
  Gain (loss) from operations       131     (620 )   (551 )   (2,252 )
  Other income (loss)       37     46     (606 ) 1   74  
  Income (loss) from continuing operations before income taxes       168     (574 )   (1,157 )   (2,178 )
  Income taxes       --     --     (3 )   3  
  Income (loss) from continuing operations       168     (574 )   (1,154 )   (2,181 )
  Gain on sale of discontinued operations, net of taxes       --     --     --     18,726 2
  Loss from discontinued operations, net of taxes       --     --     --     (3 )
  Net income (loss)       168     (574 )   (1,154 )   16,542  
  Net (income) loss attributable to noncontrolling interest       (45 )   150     122     538  
  Net income (loss) attributable to Intelligent Systems Corporation     $ 123   $ (424 ) $ (1,032 ) $ 17,080  
  Earnings (loss) per share attributable to Intelligent Systems Corporation:                            
  Basic earnings (loss) per share     $ 0.01   $ (0.05 ) $ (0.12 )  $ 1.93  
  Diluted earnings (loss) per share     $ 0.01   $ (0.05 ) $ (0.12 )  $ 1.91  
  Basic weighted average common shares outstanding       8,731,299     8,731,299     8,731,299     8,832,067  
  Diluted weighted average common shares outstanding       8,868,692     8,731,299     8,731,299     8,921,677  
                               
  1. Includes write-down of $750,000 on carrying value of investment in early stage technology company.
  2. Reflects sale of ChemFree subsidiary on March 31, 2015.
   
   
CONSOLIDATED BALANCE SHEETS  
(in thousands)  
   
As of     September 30, 2016     December 31, 2015  
ASSETS     (unaudited)     (audited)  
Current assets:              
Cash   $ 16,203   $ 18,059  
Marketable securities     431     396  
Accounts receivable, net     852     962  
Other current assets     1,063     2,846  
Restricted cash     2,200     2,200  
Total current assets     20,749     24,463  
Investments     233     1,015  
Property and equipment, at cost less accumulated depreciation     610     636  
Other long-term assets     99     59  
Total assets   $ 21,691   $ 26,173  
               
LIABILITIES AND STOCKHOLDERS’ EQUITY              
Current liabilities:              
Accounts payable   $ 222   $ 78  
Deferred revenue, current portion     1,446     1,830  
Accrued payroll     578     495  
Accrued expenses     31     25  
Other current liabilities     288     243  
Liabilities from discontinued operations     --     120  
Total current liabilities     2,565     2,791  
Deferred revenue, net of current portion     89     195  
Other long-term liabilities     18     18  
Total Intelligent Systems Corporation stockholders’ equity     22,022     26,048  
Noncontrolling interest     (3,003 )   (2,879 )
Total stockholders’ equity     19,019     23,169  
Total liabilities and stockholders’ equity   $ 21,691   $ 26,173  
               

 

For further information, call Karen Reynolds, 770-564-5503 or email to karen@intelsys.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 62

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 271

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 718

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 135

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 255

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 410

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 105

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 325

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 139

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 190

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading

Top 5 Most Recently Viewed Articles

IONQ Achieves Record Stock Levels Amid Strong Growth Indicators

Updated Category News Views 243

IONQ Stock Reaches New Heights Recently, IONQ has made headlines as its stock skyrocketed to an unprecedented level of $47.41, marking a significant achievement for the company. With a robust market capitalization of $10.2 billion, this remarkable performance is a testament to the company's impressive growth trajectory and the strong belief investors hold in its future....

Continue Reading
Model 1 Commercial Vehicles Expands Leadership Team for Growth

Updated Category News Views 285

Model 1 Commercial Vehicles Announces Leadership Changes Model 1 Commercial Vehicles is thrilled to unveil a set of key leadership appointments aimed at enhancing its strategic direction and ensuring the company's ongoing success. These changes reflect the impressive growth trajectory the company has experienced over the past few years. Tony Matijevich Takes the Helm as...

Continue Reading
Texas Instruments: Unusual Options Trends Uncovered

Updated Category News Views 195

Texas Instruments Options Insights Financial powerhouses have made a notable bullish move on Texas Instruments. Our analysis reveals intriguing trends within the options market for Texas Instruments (NASDAQ: TXN), showcasing an unusual number of trades that pinpoint shifting market sentiments. Trading Sentiment Overview Diving deeper into the data, it appears that 58% of...

Continue Reading
SMCP Unveils Latest Interim Financial Report for 2025

Updated Category News Views 177

SMCP Announces Availability of Its Interim Financial Report SMCP is excited to share that its interim financial report for the six-month period ending June 30, 2025, is now available for public access. This report has been officially filed with the relevant regulatory authorities. Details on the Financial Report This financial report outlines the company's performance...

Continue Reading
Kevin O'Leary Discusses Business Leaders' Support for Trump

Updated Category News Views 159

Understanding O'Leary's Perspective on Business Leadership Kevin O’Leary, a prominent entrepreneur and investor from Shark Tank, has provided insight into the evolving relationship between business leaders and President Trump. In recent discussions, O’Leary emphasized that the admiration many tech CEOs and corporate leaders have for Trump is not solely about his tax...

Continue Reading